Highbridge Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-45,600
| Closed | -$1.32M | – | 930 |
|
|
2017
Q1 | $1.32M | Buy |
45,600
+32,937
| +260% | +$956K | 0.02% | 453 |
|
|
2016
Q4 | $416K | Buy |
+12,663
| New | +$416K | 0.01% | 695 |
|
|
2016
Q2 | – | Sell |
-9,991
| Closed | -$363K | – | 1117 |
|
|
2016
Q1 | $363K | Sell |
9,991
-33,167
| -77% | -$1.21M | 0.01% | 601 |
|
|
2015
Q4 | $1.73M | Buy |
+43,158
| New | +$1.73M | 0.03% | 396 |
|
|
2014
Q4 | – | Sell |
-13,027
| Closed | -$278K | – | 824 |
|
|
2014
Q3 | $278K | Sell |
13,027
-24,075
| -65% | -$514K | ﹤0.01% | 740 |
|
|
2014
Q2 | $833K | Buy |
37,102
+8,189
| +28% | +$184K | 0.01% | 445 |
|
|
2014
Q1 | $731K | Sell |
28,913
-21,186
| -42% | -$536K | 0.01% | 462 |
|
|
2013
Q4 | $1.15M | Buy |
+50,099
| New | +$1.15M | 0.01% | 398 |
|